Lactate Dehydrogenase-to-Albumin Ratio and Ventricular Aneurysm Risk in STEMI Patients

551, 471, and 1384 participants across three cohorts were analyzed to evaluate a novel biomarker's predictive power. The dataset contains results from a multi-center study in China conducted from July 2018 to 2025. It was authored by Dong Hu and shared on figshare under a CC-BY-4.0 license.

Use Cases

• Developing risk prediction models for left ventricular aneurysm based on the lactate dehydrogenase-to-albumin ratio.
• Validating the LAR biomarker against established clinical variables across multiple patient cohorts.
• Conducting subgroup analyses to assess the consistency of biomarker performance in different patient populations.

Strengths

• Data is derived from a multi-center study across three cohorts, totaling 2406 participants.
• Analysis includes multivariate logistic regression and restricted cubic spline plots, suggesting a structured analytical approach.
• The dataset is small (11.5 KB), facilitating quick download and initial exploration.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment for large-scale modeling.
• Data may reflect geographic bias inherent to its collection from three medical centers in China.

Provenance

Source

figshare

Collection Method

Clinical study data from STEMI patients who underwent primary percutaneous coronary intervention.

Time Range

July 2018 to 2025

Freshness

Last updated 2026-05-13 04:30:11; freshness should be verified.

Geography

Three medical centers in China